Financial comparisons Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 20/06/2025			5-day change	1st Jan Change
162,200.00 ^KRW	+1.25%		+0.87%	-10.03%

06-19	Celltrion Healthcare UK Limited Opens New UK Headquarters in Uxbridge, UK	CI
06-16	Celltrion, Inc. Announces U.S. FDA Approval of Additional Presentation of Steelara®? (Ustekinumab-Stba)	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
CELLTRION, INC.	2.41B	11.88%	13.83%	2.46%	2.14%	1.28x
LONZA GROUP AG	7.25B	9.67%	17.9%	6.77%	3.48%	1.5x
BEONE MEDICINES LTD.	3.81B	-16.92%	-14.91%	-18.77%	-11%	4.06x
IQVIA HOLDINGS INC.	15.4B	8.91%	20.12%	33.53%	5.12%	3.33x
EUROFINS SCIENTIFIC SE	7.2B	5.84%	14.63%	7.8%	3.73%	1.93x
TEMPUS AI, INC.	693M	-107.63%	-20.47%	-	-25.37%	0.13x
ICON PUBLIC LIMITED COMPANY	8.28B	9.56%	19.29%	12.39%	6.87%	1.66x
ASCENDIS PHARMA A/S	376M	-103.97%	-76.66%	-	-37.71%	-1.14x
QIAGEN N.V.	1.98B	4.23%	28.66%	13.31%	8.32%	0.34x
MODERNA, INC.	3.24B	-110.04%	-121.91%	-28.77%	-21.87%	1.87x
MEDPACE HOLDINGS, INC.	2.11B	19.17%	21.38%	58.42%	21.52%	-1.39x
BLUEPRINT MEDICINES CORPORATION	509M	-13.19%	-41.67%	-31.26%	-21.6%	-0.14x
BIO-TECHNE CORPORATION	1.16B	14.5%	31.94%	14.11%	6.29%	0.4x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.05B	0.25%	19.9%	15.1%	6.78%	2.05x
IONIS PHARMACEUTICALS, INC.	705M	-64.4%	-67.38%	-93.12%	-15.15%	2.26x
HANGZHOU TIGERMED CONSULTING CO., LTD	905M	6.14%	7.92%	1.94%	1.39%	0.45x
TELIX PHARMACEUTICALS LIMITED	485M	6.37%	11.65%	16.85%	6.29%	-1.41x
Average	3.56B	-18.8%	-7.99%	0.72%	-3.58%	1.01x
Weighted average by Cap.	5.12B	-11.67%	-1.27%	3.81%	-2.48%	1.55x